» Authors » Jinjuan Fu

Jinjuan Fu

Explore the profile of Jinjuan Fu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 265
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Z, Chen Q, Chen Q, Hou J, Li X, Fu J, et al.
J Inflamm Res . 2024 Dec; 17:11291-11303. PMID: 39720698
Background: Increased levels of remnant cholesterol (RC) and inflammation are linked to higher risks of atherosclerotic cardiovascular disease. Whether a combination of C-reactive protein (CRP) and RC improves the predictive...
2.
Fu J, Qin X, Huang Y, Tang L, Liu Y
Sensors (Basel) . 2022 Mar; 22(5). PMID: 35271024
Vehicle-to-vehicle (V2V) communication has attracted increasing attention since it can improve road safety and traffic efficiency. In the underlay approach of mode 3, the V2V links need to reuse the...
3.
Fu J, Li F, Tang Y, Cai L, Zeng C, Yang Y, et al.
J Am Heart Assoc . 2021 Oct; 10(20):e022453. PMID: 34622672
Irisin, a novel hormone like polypeptide, is cleaved and secreted by an unknown protease from a membrane-spanning protein, FNDC5 (fibronectin type III domain-containing protein 5). The current knowledge on the...
4.
Fu J, Tang Y, Zhang Z, Tong L, Yue R, Cai L
Mol Med . 2021 Aug; 27(1):90. PMID: 34412590
Background: It is known that increased gastrin concentration is negatively correlated with cardiovascular mortality, and plasma gastrin levels are increased in patients after myocardial infarction (MI). However, whether gastrin can...
5.
Liu C, Li X, Fu J, Chen K, Liao Q, Wang J, et al.
Hypertens Res . 2021 May; 44(8):906-917. PMID: 33972750
Angiotensin II type 1 receptor (ATR) is a vital therapeutic target for hypertension. Sorting nexin 1 (SNX1) participates in the sorting and trafficking of the renal dopamine D receptor, while...
6.
Fu J, Han Y, Wang J, Liu Y, Zheng S, Zhou L, et al.
J Am Heart Assoc . 2016 Dec; 5(11). PMID: 27912206
Background: Exercise is a major nonpharmacological treatment for hypertension, but its underlying mechanisms are still not completely elucidated. Irisin, a polypeptide containing 112 amino acids, which is secreted mainly by...
7.
Xia T, Guan W, Fu J, Zou X, Han Y, Chen C, et al.
Biochem Biophys Res Commun . 2016 Mar; 474(3):599-605. PMID: 27018249
Tirofiban, a glycoprotein IIb/IIIa inhibitor, is an antiplatelet drug extensively used in patients with acute coronary syndrome (ACS) and exerts an therapeutic effect on no-reflow phenomenon during percutaneous coronary intervention...
8.
Gao Z, Han Y, Hu Y, Wu X, Wang Y, Zhang X, et al.
PLoS One . 2016 Feb; 11(2):e0149032. PMID: 26866373
Both oxidative stress and inflammation are involved in the pathogenesis of contrast-induced nephropathy (CIN). Epigallocatechin-3-gallate (EGCG), a purified catechin from green tea, has antioxidant and anti-inflammatory effects. However, it is...
9.
Cai Y, Yang Y, Chen X, Wu G, Zhang X, Liu Y, et al.
Cardiovasc Res . 2016 Feb; 112(3):714-724. PMID: 26857419
Aims: Long non-coding RNAs (lncRNAs) have been found to be involved in the pathogenesis of coronary artery disease (CAD). However, it remains to be established whether or not circulating lncRNAs...
10.
Wang X, Wang J, Luo H, Chen C, Pei F, Cai Y, et al.
Free Radic Biol Med . 2015 Jun; 86:322-30. PMID: 26073126
Cardiovascular diseases, such as hypertension, could be programmed in fetal life. Prenatal lipopolysaccharide (LPS) exposure in utero results in increased blood pressure in offspring, but the vascular mechanisms involved are...